What is meant by a cofactor, such as Ureaplasma, in the context of Acquired Immune Deficiency Syndrome (AIDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

AIDS Cofactor Definition

A cofactor for AIDS refers to an infectious agent or condition that facilitates HIV transmission, accelerates disease progression, or worsens outcomes in HIV-infected individuals by enhancing viral replication, increasing infectiousness, or compromising immune function. 1

Mechanism of STD Cofactors in HIV/AIDS

The term "cofactor" in the AIDS context primarily describes sexually transmitted diseases (STDs) that create a synergistic relationship with HIV, termed "epidemiological synergy." 1

How STD Cofactors Facilitate HIV Transmission

Ulcerative STDs (syphilis, chancroid, herpes):

  • HIV is routinely detected in genital ulcer exudate from HIV-infected individuals 1
  • Ulcers bleed easily and provide direct mucosal contact during sexual activity, creating entry points for HIV 1
  • These infections increase HIV transmission risk by 2-5 fold 1

Non-ulcerative STDs (gonorrhea, chlamydia, trichomoniasis):

  • Inflammatory STDs increase both the prevalence of HIV shedding and viral load in genital secretions 1
  • Gonococcal infection increases HIV RNA shedding in semen tenfold, though effective treatment rapidly reduces this to baseline 1
  • Both ulcerative and non-ulcerative STDs attract CD4+ lymphocytes to infection sites, providing target cells for HIV 1

Specific Examples of AIDS Cofactors

Bacterial STDs as Cofactors

The major treatable STDs with strong cofactor evidence include: 1

  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum (syphilis)
  • Haemophilus ducreyi (chancroid)
  • Trichomonas vaginalis

Ureaplasma as a Potential Cofactor

Ureaplasma species have been proposed as AIDS cofactors, though evidence remains limited. 2, 3

  • Genital Ureaplasma infections occur with increasing frequency in HIV-infected patients 2
  • Ureaplasma may act as a candidate cofactor in AIDS pathogenesis through immune system activation or oxidative stress mechanisms 3
  • However, studies show Ureaplasma prevalence in HIV-positive asymptomatic women is similar to HIV-negative populations, making a direct pathogenic role uncertain 4

Mycoplasma Species as Cofactors

Three mycoplasmas have been specifically implicated: 3

  • Mycoplasma fermentans
  • Mycoplasma penetrans (serological studies suggest association with HIV infection)
  • Mycoplasma pirum

These organisms share the capacity to invade eukaryotic cells and may influence HIV pathogenesis through immune activation, superantigen production, or contribution to oxidative stress. 3

Clinical Significance of the Cofactor Concept

The population-attributable risk of non-ulcerative STDs (especially chlamydia and gonorrhea) for HIV transmission may exceed that of ulcerative STDs due to their higher incidence and prevalence, despite lower individual transmission risk. 1

Important Caveats

  • While cytomegalovirus and mycoplasmas have been studied as cofactors, most evidence comes from in vitro data requiring clinical confirmation 5
  • The responsibility of cofactors in accelerating disease progression versus HIV alone remains incompletely understood 5
  • Not all organisms isolated from HIV-infected individuals necessarily function as true cofactors—some may be commensals or markers of sexual behavior rather than causative agents 6, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ureaplasma: current perspectives.

Indian journal of medical microbiology, 2015

Research

AIDS-associated mycoplasmas.

Annual review of microbiology, 1994

Research

[HIV cofactors in the course of AIDS].

Presse medicale (Paris, France : 1983), 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.